SR-2566

N/A

Report date: 2023/10/10 16:11:15

Base Information

Drug NameSR-2566

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionArachidonic acid inhibitorsLeukotriene B4 receptor antagonistsCysteinyl leukotriene receptor 1 antagonists

TargetsArachidonic acidLeukotriene B4 receptorCysteinyl leukotriene receptor 1

Therapy Area/IndicationsInflammationSkin Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeo Pharma A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLeo Pharma A/S

Active IndicationsN/A

Inactive IndicationsInflammationSkin Diseases

ATC CodeN/A